ClinicalTrials.gg
Drug

Trospium clinical trials

Includes 18 studies of Trospium chloride.

studies test it
42
open now
28
in phase 3
22
first study started
2009

Counted the way a researcher would: Trospium with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses trospium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the trospium studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 May 2004 · SANCTURA · NDA 021595 (FDA, Drugs@FDA; as trospium chloride)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Trospium
1

In one entry with another drug

Given together, or one or the other

KarXT
21
Xanomeline/Trospium Chloride
6
Xanomeline/Trospium
2
Xanomeline and trospium chloride
2

Studies by the year they started

41 studies that test it; most in 2025 (16); 1 more planned to start later

Studies that test trospium, by start year
YearStudies
20093
20102
20131
20161
20202
20221
20232
20243
202516
202610

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
1
Phase 3
22
Phase 4
11
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 35 · Other 7

Bristol-Myers Squibb (18) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company (11) · Allergan (5) · Becky Clarkson (1) · Karuna Therapeutics (1) · University of North Carolina, Chapel Hill (1) · Vanguard Research Group (1) · Collaborative Neuroscience Research, LLC (1)

Often tested with

Tested in the same studies.

Xanomeline (33) · Omeprazole (1) · Metformin (1) · Tamsulosin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 11, 6 in phase 3

Studies that test trospium, phase 3 first.

Studies

Open first, then newest update. How each study uses trospium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 42

See all 42 studies that test trospium →

Given beside what is tested · 11 — trospium is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with trospium

Codes

What other systems call trospium · ClinicalTrials.gg INT017974

  • UNII (FDA) T4Y8ORK057TROSPIUMConfirmed FDA, Wikidata
  • RxNorm 236778Confirmed FDA, Wikidata
  • Wikidata Q513396trospiumConfirmed FDA, Wikidata
  • NCI Thesaurus C78080TrospiumOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.